Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C
Journal of Thrombosis and Haemostasis · 2025-09 · 23 (9) · 2837-2848
DOI: 10.1016/j.jtha.2025.05.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-09. Verfasst von Musan Yan und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Blood Coagulation, Protein C, Ischemic Stroke, Apolipoproteins A. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, Taishan Scholar Foundation of Shandong Province, Excellent Young Scientists Foundation of Shandong Province.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Inflammation is crucial in regulating coagulation and hemostasis. While prior research shows that apolipoprotein A-IV (ApoA-IV) has anti-inflammatory and antiplatelet effects, its specific impact on coagulation remains unclear. OBJECTIVES: To investigate the effects of ApoA-IV on the coagulation system, including its interactions with potential targets and the underlying mechanisms. METHODS: Plasma ApoA-IV levels in deep vein thrombosis patients were tested by enzyme-linked immunosorbent assay. The effects of ApoA-IV on coagulation were assessed through thromboelastography. Potential interactions and mechanisms were analyzed using surface plasmon resonance and AlphaFold 3. Mice bleeding and stroke models were employed to evaluate the effects on hemostasis and thrombosis. RESULTS: ApoA-IV levels were reduced in deep vein thrombosis patients and correlated with increased thrombotic risk. Thromboelastography showed that ApoA-IV treatment delayed clot reaction and kinetic times while decreasing thrombus generation angle and maximum amplitude, highlighting its crucial role in inhibiting coagulation and platelet aggregation. We identified ApoA-IV as a functional activator of activated protein C (APC), with critical interactions occurring at residues 144 to 148 within the exosite loop of the APC protease domain. In animal models, anti-ApoA-IV antibody administration shortened bleeding time but exacerbated ischemic stroke outcomes. Notably, inhibitory peptide HE5, which inhibits ApoA-IV-APC interaction, effectively counteracted the anticoagulant activity of ApoA-IV. CONCLUSION: These findings establish ApoA-IV as a pivotal regulator of coagulation and hemostasis, primarily through enhancing APC activity. This research advances our understanding of the interplay between inflammation, lipid metabolism, and thrombosis, offering insights for developing novel antithrombotic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Qingdao University, Qingdao, Shandong, China.
- Department of Vascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
- The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, Shandong, China.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Toronto Platelet Immunobiology Group…
- Department of Emergency, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Center Medical Group), Qingdao, Shandong, China.
- Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Förderung
- Shandong Province Natural Science Foundation
- Taishan Scholar Foundation of Shandong Province
- Excellent Young Scientists Foundation of Shandong Province
- National Natural Science Foundation of China
- Heart and Stroke Foundation of Canada
- Qingdao University
- Shandong Provincial Postdoctoral Science Foundation
- Qingdao Key Health Discipline Development Fund
Zitieren
APA
Yan, M., Wang, Y., Niu, L., Wang, S., Yu, H., Yin, Q., Zhang, D., Bai, Y., Yin, Y., Lin, S., Liu, C., Zhang, M., Tang, X., Ni, H., Xue, M., & Li, C. (2025). Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C. Journal of Thrombosis and Haemostasis, 23(9), 2837-2848. https://doi.org/10.1016/j.jtha.2025.05.033
Vancouver
Yan M, Wang Y, Niu L, Wang S, Yu H, Yin Q, et al. Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C. Journal of Thrombosis and Haemostasis. 2025;23(9):2837-2848. doi:10.1016/j.jtha.2025.05.033
BibTeX
@article{Yan2025,
author = {Yan, Musan and Wang, Yuewei and Niu, Liyuan and Wang, Shaoying and Yu, Haichu and Yin, Qikai and Zhang, Dachuan and Bai, Yunduo and Yin, Yuanjie and Lin, Shiping and Liu, Chuanfeng and Zhang, Mingxue and Tang, Xiaopeng and Ni, Heyu and Xue, Min and Li, Changjiang},
title = {Apolipoprotein A-IV regulates coagulation and ischemic stroke by potentiating activated protein C},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {9},
pages = {2837--2848},
doi = {10.1016/j.jtha.2025.05.033}
}
EUVIMED